For the quarter ending 2025-12-31, SNOA made $4,349K in revenue. -$645K in net income. Net profit margin of -14.83%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenues | 4,349 | 5,604 | 3,754 | 3,564 |
| Cost of revenues | 2,699 | 3,484 | 2,226 | 2,294 |
| Gross profit | 1,650 | 2,120 | 1,528 | 1,270 |
| Research and development | 557 | 575 | 411 | 427 |
| Selling, general and administrative | 1,771 | 1,882 | 1,773 | 1,874 |
| Total operating expenses | 2,328 | 2,457 | 2,184 | 2,301 |
| Loss from operations | -678 | -337 | -656 | -1,031 |
| Other (expense) income, net | -271 | -394 | 128 | 112 |
| Net loss before income taxes | -949 | -731 | -528 | -919 |
| Income tax benefit (expense) | -130 | -197 | 248 | 9 |
| Net loss | -819 | -534 | -776 | -928 |
| Foreign currency translation adjustments | 174 | 205 | 178 | -357 |
| Comprehensive loss | -645 | -329 | -598 | -1,285 |
| Basic EPS | -0.48 | -0.32 | -0.482 | -0.63 |
| Diluted EPS | -0.48 | -0.32 | -0.482 | -0.63 |
| Basic Average Shares | 1,713,000 | 1,646,000 | 1,241,000* | 1,464,000 |
| Diluted Average Shares | 1,713,000 | 1,646,000 | 1,241,000* | 1,464,000 |
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)